INIFY LABORATORIES AB
Research INIFY LABORATORIES AB (WY60) on Bullrun: market cap EUR 50.94M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerWY60
- ExchangeF
- CountrySweden
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyEUR
- Market capEUR 50.94M
- Financial periodQ1 2026
- RevenueEUR 5.98M
- Net income-EUR 21.47M
- Gross margin85.2%
Valuation Snapshot
latest market cap is EUR 50.94M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 22.01M | -EUR 67.89M | n/a | 84.5% | -0.85 | EUR 57.53M | n/a | EUR 106.54M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-29 | EUR 50.94M | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About INIFY LABORATORIES AB
INIFY Laboratories AB provides cancer diagnostics services in Sweden. It offers prostate cancer diagnostics services. The company was incorporated in 2021 and is based in Stockholm, Sweden.
Related stock research
Other Healthcare stocks
ALPHAHELIX MOL.DIAGN. SK1 (4MB)
Spermosens AB (publ) (9R5)
Neovici Holding AB (publ) (IDLDX)
Immunovia publ AB (IMMNOV)
Prostatype Genomics AB (publ) (PGO0)
Prostatype Genomics AB (PROGEN)
SenzaGen AB (SENZA)
Vimian Group AB (VIMIAN)
ODINWELL AB (0AF)
Camurus AB (0RD1)
Flerie AB (publ) (1NP1)
PEPTONIC MEDICAL (28L)
Frequently asked questions
What is INIFY LABORATORIES AB's market cap?
INIFY LABORATORIES AB's market capitalization is EUR 50.94M.
What does INIFY LABORATORIES AB do?
INIFY Laboratories AB provides cancer diagnostics services in Sweden. It offers prostate cancer diagnostics services. The company was incorporated in 2021 and is based in Stockholm, Sweden.